PSG RxWire
Advancing and protecting our clients' interests in the pharmacy benefit marketplace for more than 20 years.
DRUGS APPROVED

FDA Approves New Drug for Gaucher's Disease: Cerdelga

FDA approves GSK's Promacta for treatment of SAA

FDA approves Mylan’s Precedex generic

FDA approves GSK’s Arnuity Ellipta to treat asthma in US


Specialty Rx
SUMMARY OF TOP ARTICLES - AUGUST 28, 2014

Weighing Pradaxa’s Risks
New York Times - August 18, 2014
Patients taking traditional blood thinners like warfarin must have tests every few weeks to ensure that blood levels of the drug are in an acceptable range. But 2010 brought a seemingly welcome alternative: Pradaxa.

In Move to Curb Drug Abuse, D.E.A. Tightens Rule on Widely Prescribed Painkiller
New York Times - August 21, 2014
The federal government tightened the prescribing for the most common form of painkiller in the country on Thursday, the final step in a policy shift that has been years in the making.

California legislators approve naloxone dispensing without Rxs
Drug Topics - August 20, 2014
California lawmakers recently passed a bill that would allow pharmacists to furnish naloxone without a prescription according to guidelines yet to be established by the state’s pharmacy and medical boards.

Early Research With Drug Restores Hair in Patients With Alopecia
HealthDay News - March 00, 2014
A drug used to treat a rare type of bone marrow cancer restores hair in patients with an autoimmune disease that causes hair loss, a new study found.

'Off-label' use to treat dementia-related behavior may carry significant risks, study finds
HealthDay News - August 19, 2014
Kidney injury can be added to the list of possible harms related to use of three antipsychotic medications often prescribed to treat behavioral symptoms of dementia in older adults, a new study finds.

OIG finds risk of abuse in specialty pharmacy’s per-fill fee proposal
Lexology - August 22, 2014
In an Advisory Opinion posted August 15, 2014, the Office of Inspector General (“OIG”) concluded that a proposed arrangement by a specialty pharmacy (“Requestor”) might generate prohibited remuneration under the Federal anti-kickback statute and would pose a risk of fraud and abuse.

Roche paying $8.3 billion for InterMune and its ‘breakthrough’ respiratory drug
Fortune - August 25, 2014
Deal gives the Swiss pharmaceutical giant access to InterMune’s innovative therapies.

Nonprofit Hospitals’ 2013 Revenue Lowest Since Recession, Report Says
New York Times - August 27, 2014
Nonprofit hospitals last year had their worst financial performance since the Great Recession, according to a report released on Wednesday. The poor operating performance of many hospitals underscored some of the changes in the health care system as the federal government and private health plans became less willing to pay for hospital care and changed the way they paid hospitals in an effort to reduce costs.

New statin guidelines an improvement, study shows
ScienceDaily - August 26, 2014
New national guidelines can improve the way statin drugs are prescribed to patients at risk for cardiovascular disease, a study has found. The research also showed the new guidelines produce only a modest increase in the number of patients being given the drugs.

The Affordable Care Act supports patient-centered medical homes in health centers
U.S. Department of Health & Human Services - August 26, 2014
Obama administration awards over $35 million to support facility improvements in 147 health centers nationwide to deliver better coordinated care

Big Drop in U.S. Heart-Related Hospitalizations and Deaths, Study Finds
HealthDay News - August 18, 2014
Lifestyle changes, wider use of medications driving the trend, researchers say.

Cancer-fighting drugs might also stop malaria early
ScienceDaily - August 25, 2014
Scientists searching for new drugs for malaria have identified a number of compounds -- some of which are in clinical trials to treat cancer -- that could lead to new ways to fight the disease. Researchers identified 31 enzyme-blocking molecules, called protein kinase inhibitors, that curb malaria before symptoms start. By focusing on treatments that act early, the researchers hope to give drug-resistant strains less time to spread.


Contact,

Kristin LaVitola
Marketing Director, PSG
Pharmaceutical Strategies Group (PSG)
Office: 972-244-8388
Email: KLavitola@PSGConsults.com

PSGNewsletter@PSGConsults.com
www.PSGConsults.com